Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$23.50 – $27.00
87% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $471.7M | $534.7M | $556.0M | $573.8M | $683.9M | $763.0M | $872.0M | $951.8M |
| Cost of revenue | $263.4M | $294.7M | $309.2M | $326.3M | $397.7M | $430.4M | $476.3M | $806.7M |
| Gross profit | $208.3M | $240.0M | $246.7M | $247.5M | $286.2M | $332.6M | $395.7M | $145.1M |
| Gross margin | 44.2% | 44.9% | 44.4% | 43.1% | 41.8% | 43.6% | 45.4% | 15.2% |
| R&D | $1.2M | $1.4M | $2.1M | $2.2M | $2.3M | $2.7M | $0 | $0 |
| Operating income | $73.5M | $84.4M | $88.7M | $87.4M | $97.9M | $108.6M | $130.7M | $146.2M |
| EBITDA | $82.2M | $108.0M | $112.1M | $111.3M | $129.7M | $134.1M | $158.1M | $192.6M |
| Net income | $42.5M | $41.1M | $59.6M | $61.0M | $69.6M | $70.5M | $80.6M | $91.0M |
| Net margin | 9.0% | 7.7% | 10.7% | 10.6% | 10.2% | 9.2% | 9.2% | 9.6% |
| EPS (diluted) | 0.59 | 0.56 | 0.82 | 0.84 | 0.96 | 0.97 | 1.10 | 1.24 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $1.1B | $1.42 | $1.38–$1.48 | 1 |
| 2027 | $1.2B | $1.59 | $1.54–$1.66 | 1 |
| 2028 | $1.3B | $1.82 | $1.77–$1.90 | 1 |
| 2029 | $1.5B | $2.36 | $2.29–$2.46 | 1 |
Forward consensus · source: Financial Modeling Prep
FAGRON SA ORD
No one on the platform currently holds ARSUF.
No tracked institution reports a position in ARSUF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-19 | $0.4000 | 2026-05-20 |
| 2025-05-20 | $0.3500 | 2025-05-21 |
| 2024-05-21 | $0.3000 | 2024-05-23 |
No one on the platform has traded ARSUF yet.
| $1.3B |
| — |
| GTBIFGreen Thumb Industries Inc. | $7.49 | +1.35% | $1.7B | — |
| HTSUFHisamitsu Pharmaceutical Co., Inc. | $29.00 | +0.00% | $2.0B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 13.9× earnings vs its 17.8× historical median P/E.
Fair value ≈ $34.04 · price $26.53 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.